Sleeping Aids Providing Comfort to Sleep Apnea Patients

 The American Sleep Apnea Association says that at present, around 22 million people in the U.S. suffer from sleep apnea. Among these, around 80% of cases of severe and moderate obstructive sleep apnea (OSA) remain undiagnosed. OSA can affect infants as well as adults; however, it is most frequent among men over 40 years. This disorder is highly prevalent among overweight or obese men. Thus, the surging cases of sleep disorders, such as OSA and insomnia, will create a huge requirement for sleeping aids in the coming years.

Browse detailed report with COVID-19 impact analysis on Sleeping Aids Market Report

In recent years, BRAEBON Medical Corporation, Takeda Pharmaceutical Company Limited, Löwenstein Medical GmbH & Co. KG, Natus Medical Incorporated, GlaxoSmithKline plc, Merck & Co. Inc., ResMed Inc., and Koninklijke Philips N.V. have been focusing on the production of sleep apnea devices, mattress and pillows, and medication and offering sleep laboratory services. In contemporary times, mattresses and pillows are being preferred over other sleeping aids due to their cost-effectiveness and availability in wide varieties. These products are used to comfort and treat patients suffering from insomnia, sleep apnea, narcolepsy, restless leg syndrome (RLS), and sleepwalking.

Currently, sleeping aids manufacturers are engaging in product launches and partnerships and collaborations to reach out to a greater number of customers. For instance, in September 2019, Koninklijke Philips N.V. introduced its expanded SmartSleep suite of solutions in the U.S. These solutions assist users in addressing an array of sleep issues, ranging from difficulty in falling asleep to snoring. Furthermore, in January 2020, SleepScore Labs partnered with Serta Simmons Bedding LLC (SSB) to explore the effects of sleeping on the iComfort by Serta CF4000 mattress and its ability to offer restful and comfortable sleep.

Whereas, the Asia-Pacific (APAC) sleeping aids market is expected to progress at the highest rate in the foreseeable future. This will be due to the increasing consumption of sleeping pills, booming geriatric population, and rising burden of sleeping disorders. According to the United Nations Population Fund (UNFPA), the population of people aged 60 years or above in the region will reach around 1.3 billion by 2050. Moreover, the low manufacturing cost of the products, owing to the easy availability of raw materials and labor, will support the market growth in the region.

Thus, the mounting cases of sleeping disorders and escalating demand for sleeping pills will fuel the adoption of sleeping aids.

Read More

Global Sleeping Aids Market is Projected to Grow at a Decent Pace for the Next Few Year

The global sleeping aids market is being driven by the increasing geriatric population, rising prevalence of obstructive sleep apnea (OSA) and insomnia, and expanding healthcare sector. It generated a revenue of $69.5 billion in 2017 and is slated to grow at a CAGR of 6.5% during the forecast period (2018–2023). Sleeping aids are medical devices and drugs that assist a person in falling asleep. Products in the market range from sleep apnea devices and medication to mattresses and pillows, and sleep laboratory devices.

The sleeping aids market is observing the rising popularity of wearable sensors and monitoring devices. Besides recording physiological parameters of a patient’s body, these devices are equipped with sensors that help in measuring the sleep quality and monitoring sleep disorders. These devices have a user-friendly design and do not require any special know-how to operate them, which makes them a popular product among patients suffering from sleep disorders. LifeVest by ZOLL Medical Corporation, BioHarness by BIOPAC Systems Inc., and Zio XT by iRhythm Technologies Inc. are some wearable monitors and sensors.

To Learn More About this Report: http://bit.ly/2LZvuFJ

In the sleeping aids market, continuous positive airway pressure (CPAP) devices are being increasingly used by sleep apnea patients. These offer uninterrupted sleep to patients by controlling snoring. This device consists of a mask that is attached to a tube, along with a pump. The demand for these devices is increasing due to technological improvements, such as a mask that covers only the nose and use of soft material. CPAP humidifiers, which keep the inside-air moist, are a type of CPAP devices manufactured by companies such as ResMed Inc., Respironics Inc., and Koninklijke Philips N.V.

Governments and various private organizations are now increasingly investing in research and development activities to find a better treatment for sleep disorders. Numerous start-ups working on finding an effective way of controlling and preventing such disorders are being supported by governments of developing and developed nations alike. This has enabled the customers to access tailor-made therapies, sleep monitoring devices, and mobile apps. For instance, Oventus Medical won a $2,950,000 Australian federal government grant in February 2017 for research on sleep apnea.

Hence, the market for sleeping aids is expected to grow because of the above-mentioned factors during the forecast period.

Read More